DateJuly 11, 2017
2017 Update: Read the commitment here.
2015:Madagascar commits to increasing the contraceptive prevalence rate to 50 percent and decreasing by half the unmet need for family planning to 9 percent by 2020.
DateJuly 11, 2017
2017 Update: Read the commitment here.
2012:Rwanda will ensure the availability of family planning services in each of the 14,841 Rwanda administrative villages (Imidugudu) through delivery by the 45,000 community health workers already in service. There are also plans to expand existing family planning communications programs to raise awareness of family planning choices. Focusing on convenience and reducing the frequency of visits to health providers, the Government of Rwanda will introduce long-lasting contraceptive methods, including permanent ones and high quality integrated family planning services in every hospital and health center.
During the London Summit on Family Planning, the government of Rwanda committed to ensuring the availability of family planning services in each of the 14,841 Rwandan administrative villages (Imidugudu) through delivery by the 45,000 community health workers already in service. In 2014, the government reported that family planning services had been scaled across the country through community health workers.
In 2015-2016, the government of Rwanda reported that family planning services were provided countrywide at community level by Community Health Workers (CHWs) and the following activities were undertaken in support of this commitment:
The government of Rwanda engaged in the following activities to expand existing family planning communications programs to raise awareness of family planning choices:
The Government of Rwanda engaged in the following activities to introduce LAPMS and high-quality integrated family planning services in hospital and health centers:
DateJuly 11, 2017
PATH seeks to improve the agency of women and girls to exercise their rights and make informed choices about their sexual and reproductive health. One way we further this goal is by developing, introducing, and scaling up high-quality, woman-centered, innovative contraceptive methods, especially in places with high unmet need.
In support of FP2020, PATH commits to expand the contraceptive method mix in 8-12 countries by 2020. We will collaborate with country governments and implementing partners to accelerate introduction and scale-up of new contraceptives as part of a broad method mix; to strengthen health systems and improve contraceptive access and choice through a range of service delivery channels that are convenient for women and girls—including community-based distribution, private retail outlets, and self-initiated options; and to help build enabling environments and sustainable markets for family planning products.
PATH also commits to improve information-sharing, exchange of experience and lessons learned, and identification of best practices on contraceptive introduction and scale-up by 2020. Specifically, we will establish a dedicated global platform to convene partners with expertise and interest in country-level introduction and scale-up of new reproductive health technologies, and facilitate the documentation and dissemination of relevant data, resources, and learning.
PATH’s commitment will focus on 8-12 FP2020 countries and involve collaboration with partners in those countries. This commitment will involve a dynamic list of countries over the three years; illustrative examples of countries, contingent on their interest and other factors, include Burkina Faso, Myanmar, Senegal, Uganda, and Zambia.
DateJuly 11, 2012
The William and Flora Hewlett Foundation will support an effort to develop and cost out options for an external accountability mechanism around the financial and political commitments made at the London Summit on Family Planning. The Hewlett Foundation also will intensify engagement in the Ouagadougou Partnership and its focus on accelerating access to family planning services in Francophone West Africa with the Gates Foundation, USAID, and the French Government.
In August 2015, the William and Flora Hewlett Foundation shared an update on progress in achieving its commitments to FP2020.
Highlights of grants made in 2014 and 2015 in Francophone West Africa include significantly increasing the Foundation’s support (along with the Bill & Melinda Gates Foundation) to the Ouagadougou Partnership Coordination Unit; providing a large, flexible grant to Marie Stopes International for developing an organizational strategy for the Sahel and testing different approaches for regional procurement and operational models; renewing support to Hope Consulting to incorporate results from the 2013 market segmentation analysis into Ministry of Health and family planning partner programming; renewing support to IntraHealth International for family planning advocacy coalitions in Benin, Burkina Faso, Mali, Niger and Senegal; and funding World Faiths Development Dialogue to engage high-level faith leaders in Senegal in dialogue with the government about how to support implementation of that country’s costed implementation plan.In September 2015 the Hewlett Foundation plans to launch a formative evaluation of our strategy for family planning and reproductive health in Francophone West Africa. The evaluation will assess the Foundation’s strategy to serve as a catalyst in the region to spur an increase in access and use of family planning and reproductive health services, both through grantmaking and active participation as a core donor of the Ouagadougou Partnership.
DateJuly 11, 2012
WHO commits to expanding choice and method mix through contraceptive research and development and assessment of the safety and efficacy of new and existing methods. In addition, it commits to scaling up the availability of high-quality contraceptive commodities through product prequalification and Expert Review Panel (ERP) fast-track mechanisms. WHO will work to synthesize and disseminate evidence on effective family planning delivery models and actions to inform policies, address barriers and strengthen programs. In the context of the Commission on Information and Accountability for Women's and Children's Health, WHO will work with countries with the highest levels of unmet needs to examine inequalities and vulnerabilities and reasons for the unmet need.
In July 2015, World Health Organization shared an update on progress in achieving its commitments to FP2020.
Expanding choice and method mix through contraceptive research and development and assessment of the safety and efficacy of new and existing methods: The WHO supported a clinical study that assesses the effectiveness of the three-year one rod etonogestrel (ENG) and the five-year two rod levonorgestrel (LNG) releasing contraceptive implants. At three years of follow-up, the trial found that annual cumulative pregnancy rate was very low and similar between both implant groups with a three-year cumulative rate of 0.4 per 100 (95% confidence interval [CI] 0.2-1.0) for both ENG- and LNG-implants users. No additional pregnancy was recorded beyond three years up to five years of follow up in 1-rod ENG and the 2-rod LNG, indicating the effectiveness of implants up to five years; including Implanon (1-rod ENG) which is currently recommended for three years of use. The results indicating that both the one rod etonogestrel (ENG) and the two rod levonorgestrel (LNG) can be effectively used for 5 years have been submitted for publication.
One of the key studies supported by WHO on safety of contraception is the Evidence for Contraceptive options and HIV Outcomes (ECHO) Trial a multi-center study designed to compare the risks of HIV acquisition between women randomized to DMPA, levonorgestrel (LNG) implant, and copper Intra-Uterine Devices (IUDs). The study is set to be initiated in 11 sites in four South and East African countries in collaboration with Family Health International 360, Wits Reproductive Health and HIV Institute and University of Washington.
Scaling up the availability of high-quality contraceptive commodities through product prequalification and Expert Review Panel (ERP) fast track mechanisms: In 2015, WHO approved the addition of three new methods in the latest edition of the WHO Essential medicines list (EML), 2015: the Levonorgestrel intra-uterine system, Progesterone vaginal ring (for use in women actively breastfeeding at least 4 times a day) and the etonorgestrel releasing hormonal contraceptive implant. As a member of the Technical Reference Team on Reproductive Health/Contraceptives within the UN Commission on Life Saving Commodities, WHO promoted access to under-utilized commodities. For contraception, this includes Levonorgestrel as emergency contraception, hormonal contraceptive implants, and the female condom. Milestones achieved include, the generation of best-practice tools for advocacy, quantification, demand generation, supply chain and provider training; and several product innovations. Slower progress was evident around regulatory harmonization and quality assurance.
Synthesizing and disseminating evidence on effective family planning delivery models and actions to inform policies, address barriers and strengthen programs: WHO in collaboration with the United States Agency for International Development (USAID) convened a technical consultation in January 2015 to discuss the implications of contraceptive classification, existing approaches of contraceptive classification, measurement of contraceptive use and proposed revisions to existing contraceptive classification system. The consultation identified the need to consistently classify Modern methods such as Lactational Amennorrhea Method (LAM) and the Standard Days Method (SDM), and to accurately report on users of emergency contraception.
WHO has published the following documents/articles to guide policy development and for research prioritization:
WHO serves as the secretariat of the Implementing Best Practices Consortium, which is made of 44 international reproductive health organizations. The main purpose of the consortium is to scale-up effective reproductive health practices. Key activities that support our commitments to FP2020, include the IBP knowledge Gateway https://knowledge-gateway.org/, a virtual platform that hosts a global community of over 60,000 reproductive health professionals where new research, tools and approaches in RH/FP as well as communities of practice addressing key issues in RH/FP are shared.
At the global level, IBP organized 28 sessions at the ICFP/Addis Conference in 2013 focused on overcoming obstacles to scaling up effective practices in FP and disseminating tools, guidelines, and approaches to knowledge sharing. At the regional level, WHO/IBP has supported West Africa Health Organization (WAHO) since 2013 to develop an approach to documenting effective practices in RH/FP and organizing a Forum of Good Practices that took place in Ouagadougou in July, 2015 and hosted over 300 participants from their 15 member states. IBP’s June, 2015 semi-annual meeting held in Addis Ababa, hosted over 200 participants from East and Southern Africa to share effective practices, tools and approaches for documenting and scaling up RH/FP practices in the region. At country level numerous countries, such as Zambia, Burkina Faso, Zimbabwe, Togo, Chad and Democratic Republic of Congo (DRC) are using tools and approaches introduced by WHO and IBP on the documentation and scale-up of effective practices in RH/FP.
Working with countries with the highest levels of unmet needs to examine inequalities, vulnerabilities and reasons for unmet need, in the context of the Commission on Information and Accountability for Women's and Children's Health: WHO is undertaking several activities to address unmet needs in family planning/contraception using strategies such as community participation, leveraging missed-opportunities and focusing on vulnerable groups.
DateJuly 11, 2017
Cycle Technologies commits to:
Globally 225 million women have an unmet need for contraception. This means that they are at risk for pregnancy, but are not using a modern contraceptive method. Each year there are also 85 million unplanned pregnancies with almost all of these – 95% - occurring to women who were not using contraception consistently at the time they became pregnant.
Fertility awareness methods, and specifically well researched, proven, easy to use methods, have the potential to reach millions of women who have unmet need with effective contraception. These options address the primary reason cited by women for not using birth control consistently – side effects. They also expand the method mix, work in a variety of cultural contexts, and can be accessed by women for free, directly through their mobile devices. Because of this, they have the potential to have a huge impact in addressing the needs of the millions of women worldwide who are at risk for pregnancy, yet are not using a modern contraceptive method.
Cycle Technologies has extensive experience in making effective, easy to use fertility awareness-based methods available widely. Research on our technologies has found that they bring new users to family planning and can reach a significant number of women who have unmet family planning need. Over 6 million women, many in the areas with the most unmet need, have successfully used these effective contraceptive options.
Recent impact studies indicate that offering these contraceptive options via mobile technology has the potential to be a game-changer. Research conducted by the Institute for Reproductive Health at Georgetown University in Kenya, Ghana, and India on Cycle Technologies’ mobile application CycleBeads show that this contraceptive app can bring new users to family planning, reaches women who are at risk for pregnancy, and can be offered cost efficiently to a massive number of women through a smartphone device.
Cycle Technologies app – Dot Fertility & Period Tracker – which is undergoing the first ever full-scale contraceptive app efficacy study in 2017, was named by Women Deliver as a Top 10 Global Health App Changing the Lives of Women and Girls.